Fighting Counterfeit Drugs with Pharmaceutical Serialization [Infographic]

Meagan Douglas
Thu, Mar 16, 2017

Pharmaceutical Serialization Counterfeit DrugsIn the fight to eliminate the multi-billion dollar counterfeit drug problem, the Drug Supply Chain Security Act (DSCSA) will require pharmaceutical manufacturers to serialize their products by November 2017. Repackagers must serialize products by November 2018.

In order to comply with the DSCSA, pharmaceutical manufacturers, repackagers, and wholesale distributors will need to be able to:

  • Properly label prescription drug product packages and cases,
  • Trace prescription drugs through the supply chain,
  • Aggregate product transaction data and store it for 6 years, and
  • Respond quickly to product verification requests and recalls.

To maximize profitability, you need to fight drug counterfeiting and improve operational efficiency by capturing serialized data in real-time. By providing your team with the tools to capture traceability and aggregated data, you can optimize many areas of your business—from production to the warehouse, and beyond.

Are you ready for the DSCSA?

Check out the infographic below, and learn how a mobile data collection solution can help you comply with the DSCSA and fight counterfiet drugs in the supply chain. 

pharmaceutical-serilaization-counterfeit-drugs-infographic.jpg

 How are you preparing for the DSCSA? Let us know in the comments. White Paper CTA.jpg

Subscribe by Email

No Comments Yet

Let us know what you think